219 related articles for article (PubMed ID: 28556023)
21. The tyrosinase enhancer is activated by Sox10 and Mitf in mouse melanocytes.
Murisier F; Guichard S; Beermann F
Pigment Cell Res; 2007 Jun; 20(3):173-84. PubMed ID: 17516925
[TBL] [Abstract][Full Text] [Related]
22. Tyrosinase gene expression in human tissues.
Battyani Z; Xerri L; Hassoun J; Bonerandi JJ; Grob JJ
Pigment Cell Res; 1993 Dec; 6(6):400-5. PubMed ID: 7511806
[TBL] [Abstract][Full Text] [Related]
23. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
Clevenger J; Joseph C; Dawlett M; Guo M; Gong Y
Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
[TBL] [Abstract][Full Text] [Related]
24. T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
Jungbluth AA; Iversen K; Coplan K; Kolb D; Stockert E; Chen YT; Old LJ; Busam K
Pathol Res Pract; 2000; 196(4):235-42. PubMed ID: 10782467
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous epithelioid angiosarcoma: a neoplasm with potential pitfalls in diagnosis.
Mobini N
J Cutan Pathol; 2009 Mar; 36(3):362-9. PubMed ID: 19220634
[TBL] [Abstract][Full Text] [Related]
26. A metastatic melanoma with an unusual immunophenotypic profile.
Gao Z; Stanek A; Chen S
Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma.
Choy B; Hyjek E; Montag AG; Pytel P; Haydon R; Luu HH; Zhen CJ; Long BC; Kadri S; Segal JP; Furtado LV; Cipriani NA
Histopathology; 2017 Apr; 70(5):734-745. PubMed ID: 27926791
[TBL] [Abstract][Full Text] [Related]
28. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical evaluation of necrotic malignant melanomas.
Nonaka D; Laser J; Tucker R; Melamed J
Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838
[TBL] [Abstract][Full Text] [Related]
30. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases.
Brenn T; Fletcher CD
Am J Surg Pathol; 2005 Aug; 29(8):983-96. PubMed ID: 16006792
[TBL] [Abstract][Full Text] [Related]
31. Macrophage-rich epithelioid angiosarcoma mimicking malignant melanoma.
Brightman LA; Demierre MF; Byers HR
J Cutan Pathol; 2006 Jan; 33(1):38-42. PubMed ID: 16441410
[TBL] [Abstract][Full Text] [Related]
32. Melan-A positive dermal cells in malignant melanoma in situ.
Danga ME; Yaar R; Bhawan J
J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
[TBL] [Abstract][Full Text] [Related]
33. Sporadic cutaneous angiosarcomas generally lack hypoxia-inducible factor 1alpha: a histologic and immunohistochemical study of 45 cases.
Abedalthagafi M; Rushing EJ; Auerbach A; Desouki MM; Marwaha J; Wang Z; Fanburg-Smith JC
Ann Diagn Pathol; 2010 Feb; 14(1):15-22. PubMed ID: 20123452
[TBL] [Abstract][Full Text] [Related]
34. Tyrosinase mRNA RT-PCR analysis as an additional diagnostic tool for the identification of melanoma cells in biological fluid samples other than blood: a preliminary report.
Savoia P; Quaglino P; Osella-Abate S; Comessatti A; Nardò T; Bernengo MG
Int J Biol Markers; 2005; 20(1):11-7. PubMed ID: 15832768
[TBL] [Abstract][Full Text] [Related]
35. MITF::CREM-rearranged tumor: a novel group of cutaneous tumors with melanocytic differentiation.
Kalmykova A; Mosaieby E; Kacerovská D; Baranovska-Andrigo V; Martínek P; Smahová S; Michal M; Michal M
Virchows Arch; 2023 Oct; 483(4):569-575. PubMed ID: 37550584
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical studies of blood group antigens ABH in cutaneous angiosarcoma.
Ikegawa S; Saida T; Ideda S; Nakajima T; Ishihara K
Am J Dermatopathol; 1992 Apr; 14(2):100-6. PubMed ID: 1566972
[TBL] [Abstract][Full Text] [Related]
37. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
38. Primary and secondary cutaneous angiosarcoma: Distinctive clinical, pathological and molecular features.
Ronchi A; Cozzolino I; Zito Marino F; De Chiara A; Argenziano G; Moscarella E; Pagliuca F; Franco R
Ann Diagn Pathol; 2020 Oct; 48():151597. PubMed ID: 32829071
[TBL] [Abstract][Full Text] [Related]
39. DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.
Fürst K; Steder M; Logotheti S; Angerilli A; Spitschak A; Marquardt S; Schumacher T; Engelmann D; Herchenröder O; Rupp RAW; Pützer BM
Cancer Lett; 2019 Feb; 442():299-309. PubMed ID: 30445206
[TBL] [Abstract][Full Text] [Related]
40. Cytologic features of angiosarcoma: A review of 26 cases diagnosed on FNA.
Geller RL; Hookim K; Sullivan HC; Stuart LN; Edgar MA; Reid MD
Cancer Cytopathol; 2016 Sep; 124(9):659-68. PubMed ID: 27088896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
